NCEL
NewcelX Ltd.
NASDAQ: NCEL · HEALTHCARE · BIOTECHNOLOGY
$3.42
+2.09% today
Updated 2026-04-29
Market cap
$17.27M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.93
Dividend yield
—
52W range
$2 – $31
Volume
0.0M
NewcelX Ltd. (NCEL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $2.29M | $145635.00 | $696429.00 | $1.21M | $5.76M | $9.28M | $1.85M | $2.23M |
| Cash & equivalents | $2.18M | $6678.00 | $220267.00 | $93710.00 | $5.43M | $8.95M | $897680.00 | $1.67M |
| Current assets | $2.27M | $90163.00 | $381746.00 | $196711.00 | $5.72M | $9.25M | $1.82M | $2.23M |
| Total liabilities | $10.01M | $8.96M | $6.87M | $10.20M | $5.22M | $6.00M | $10.68M | $826764.00 |
| Current liabilities | $989955.00 | $2.41M | $4.04M | $7.20M | $2.40M | $3.36M | $7.92M | $826764.00 |
| Long-term debt | — | — | — | — | — | $0.00 | $834000.00 | — |
| Shareholder equity | $-7.72M | $-8.81M | $-6.17M | $-8.98M | $542388.00 | $3.28M | $-8.83M | $1.41M |
| Retained earnings | $-16.30M | $-21.45M | $-26.90M | $-29.76M | $-41.71M | $-58.20M | $-70.37M | $-74.43M |
| Accounts receivable | — | $36893.00 | $75388.00 | $61207.00 | $38551.00 | $41243.00 | $10664.00 | $400000.00 |
| Inventory | — | $-9356.00 | — | $-61206.00 | $-38551.00 | $-41243.00 | — | — |
| Goodwill | — | — | — | — | — | — | — | — |